Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-70
SponsorWonju Severance Christian Hospital
About this trial
The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments?
Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery.
Participants will:
* Receive ERAS protocol during the hospitalization * Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7 * Visit the hospital at one week and one month after discharge * Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge
Eligibility criteria
Qualifiers
Age between 20 and 70 years
Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia
Use of an Android smartphone
Disqualifiers
American Society of Anesthesiologists(ASA) physical status classification IV or higher
Body Mass Index (BMI) 35 or higher
Presence of diabetic autonomic neuropathy
History of esophageal hiatal hernia or delayed stomach discharge
Trial design
Treatments tested in this trial
- Enhanced Recovery After Surgery
- Usual Care
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wonju Severance Christian Hospital
Lead sponsor
Ministry of Trade, Industry & Energy, Republic of Korea
Collaborator
Source ClinicalTrials.gov